Stephanie Kennedy, PhD, is a Director with PRECISIONadvisors. Stephanie has over 13 years of experience in biotech, with over 7 years of experience providing strategic consulting services to top pharmaceutical and biotech companies. Stephanie’s expertise spans a variety of therapeutic areas including oncology, autoimmune, infectious diseases, kidney and solid organ transplant, gene therapies and rare and orphan diseases.
Stephanie has advised clients across a broad range of project scopes, including early-stage and final launch pricing strategy, coding & reimbursement strategy, value communication and value message development, launch sequence optimization, clinical advisory boards for strategic program planning, and quantitative research. Stephanie has expertise in the US, Japanese, and Canadian markets and focuses on global commercial strategy.
Stephanie also has 6 years of research experience in medical devices for breast cancer diagnostics coupled with a PhD in Biomedical Engineering from Duke University. Stephanie completed a Bachelor of Biomedical Engineering at the Catholic University of America.